10. Pushing the Boundaries: Technological Advancements in Myoclonic Epilepsy
Technology is playing an increasingly important role in understanding and managing myoclonic epilepsy. From diagnostic tools to treatment modalities and tracking systems, technological advancements are continuously expanding the boundaries of epilepsy care.
At the diagnostic level, technology has significantly improved the precision and accessibility of tools such as electroencephalograms (EEGs). High-density EEGs, for instance, can capture brain activity with increased detail, leading to better localization of seizure origins. Similarly, advancements in genetic testing technologies have enabled comprehensive and efficient sequencing of genes associated with myoclonic epilepsy, leading to more precise diagnoses.
In terms of treatment, devices such as responsive neurostimulation systems (RNS) represent a leap forward. These systems monitor brain activity and deliver a responsive electrical stimulation to stop a seizure before it starts. The Vagus Nerve Stimulation (VNS) is another device that sends regular, mild pulses of electrical energy to the brain via the vagus nerve, thereby reducing seizure frequency.
Technology is also supporting the everyday management of epilepsy. Apps for smartphones and smartwatches can help track seizures, identify potential triggers, remind about medication times, and even alert caregivers when a seizure is taking place. (10)
